Barricade Therapeutics is a startup based in the United States.
Barricade Therapeutics is a startup based in the United States.
Barricade Therapeutics is a clinical-stage oncology company developing BT-1501, a first-in-class oral small-molecule therapy targeting the genetic drivers of colorectal cancer progression to provide a precision treatment alternative.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.